Type (acronym) | rm2 |
---|---|
Type | reference material |
Unique Nomination Number | C20RM1 |
Analyte Name | Anti-beta 2 glycoprotein I IgG antibodies |
List I, II or III | List II |
Basis for Traceability Claim | Traceable to the assigned value of WHO international standard NIBSC 21/266 via direct value transfer |
Applicable Matrices | human serum |
Identifier Number | ERM®- DA477/IFCC |
Name | Anti-β 2 GPI IgG in human serum
|
Certifying Organization | JRC expiration date :1 year after sales date, stability of CRM continuously monitored over the whole lifetime |
Quantity | Concentration of International Units |
From (0) | 200 |
To (0) | 200 |
Unit (0) | IU/mL |
From (1) | 189 |
To (1) | 211 |
Unit (1) | IU/mL |
Level of Confidence (%) | 95% |
Reference to Commutability Study Publication | Report on the collaborative study to establish the 1st WHO International Standard for anti β2GPI Immunoglobulin G in human serum, Monogioudi E. et al, Publication WHO/BS/2022.2420 |
Other Relevant Publications | European Commission, Joint Research Centre, Monogioudi, E., Martos, G., Trapmann, S. et al., The certification of the concentration of anti-β2-glycoprotein I IgG in human serum – ERM®-DA477/IFCC – Certification report, Publications Office of the European Union, 2022, DOI:10.2760/943468 |
Organization Acronym | EU - JRC |
Organization Name | European Commission - Joint Research Centre |
Organization Website | https://crm.jrc.ec.europa.eu/ |
Organization Country ISO Code | BE |
Organization Country Name | Belgium |
Analyte Category Name | Proteins |